Swiss HLG & Molecular Partners - Basel Networking event

Home » Swiss HLG & Molecular Partners - Basel Networking event

Join us for an engaging Swiss HLG networking event kindly supported by Molecular Partners. 

This is a unique opportunity to hear from renowned speakers as they explore the exciting rise of radioligand therapies. 

We are thrilled to have the following speakers:

  • Jonathan Russ and Pedro Andreu Perez, Ph.D., both Principals at IQVIA, will give a RLT – market overview including the market perspective. 
  • Roger Schibli, Head of Center for Radiopharmaceutical Sciences at PSI Paul Scherrer Institut will share his insights on RLT a vision for the future and what’s next in RLT.
  • Ivana Galetic, SVP Program Management at ARTBIO will talk about Developing RLTs and the challenges and opportunities.
  • Jeevan Virk, Radioligand Therapy (RLT) Leadership at Novartis will speak about bringing RLT to patients including capacity, logistics and positioning.
  • Julia Hepp, VP Partnering & Alliances and Michael Pitzner, General Counsel, Senior Vice President Legal and Business Development, both from Molecular Partners will exchange on partnering for RLTs and the BD Landscape. 

Don’t miss the chance to connect with industry professionals during our networking apero afterwards. 

The event will take place at the Novartis Pavillon, November 28th  from 5:30pm - 9:00pm

Registration begins at 5:30 PM — reserve your spot today!

Free for Swiss HLG members!

31 October 2024
·
,

SUBSCRIBE TO OUR NEWSLETTER

Keep up to date with the latest information by signing up to Swiss HLG newsletter!
Sign up now !

2023 © Swiss HLG | by evago.fr

Cookies settings

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram